AGP Executive Report
Last update: 6 hours agoPublic Health & Policy: More than 100 health and national security leaders signed an open letter warning that cutting U.S. funding for the Pan American Health Organization (PAHO) would weaken early disease detection across the Americas, including threats reaching U.S. farms. Medicare & Access: A new report finds only about 1 in 5 second-level Medicare Part D cancer drug appeals are overturned, with denials tied to approved uses overturned far more often than off-label rejections—highlighting how coverage rules can delay care. Cardiology & Prevention: A transplant cardiologist shares “five things” he avoids to prevent heart failure, focusing on blood pressure control, daily movement, limiting ultra-processed foods, treating sleep problems, and using proven medications when needed. Local DC Health Community: The Sports Philanthropy World 2026 conference kicks off in Washington, D.C., bringing training and funding-focused sessions to support community sports nonprofits. Health Tech & Drugs: Biocon launches Yesafili™ in the U.S., a biosimilar aflibercept product for ophthalmology conditions, expanding treatment options at the pharmacy level.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[BOND-003 Cohort C: Efficacy Results]]>](https://cdn.sanity.io/images/0vv8moc6/urologytimes/fcefa3ea23ab3f9ecb17d3a3ff9bf99ff317ca20-1920x1080.png)
Pseudo-journalism: Pink-slime
